Cellular senescence permanently arrests cell proliferation, often accompanied by a multi-faceted senescence-associated secretory phenotype (SASP). Loss of mitochondrial function can drive age-related declines in the function of many post-mitotic tissues, but little is known about how mitochondrial dysfunction affects mitotic tissues. We show here that several manipulations that compromise mitochondrial function in proliferating human cells induce a senescence growth arrest with a modified SASP that lacks the IL-1-dependent inflammatory arm. Cells that underwent mitochondrial dysfunction-associated senescence (MiDAS) had lower NAD+/NADH ratios, which caused both the growth arrest and prevented the IL-1-associated SASP through AMPK-mediated p53 activation. Progeroid mice that rapidly accrue mtDNA mutations accumulated senescent cells with a MiDAS SASP in vivo, which suppressed adipogenesis and stimulated keratinocyte differentiation in cell culture. Our data identify a distinct senescence response and provide a mechanism by which mitochondrial dysfunction can drive aging phenotypes.
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In Brief Wiley et al. show that mitochondrial dysfunction induces a senescence state termed MiDAS, causing a distinct secretion profile and mitotic arrest, which can be rescued with pyruvate. MiDAS is controlled by an NAD-AMPK-p53 pathway and occurs in progeroid mice, providing a basis for how dysfunctional mitochondria drive aging phenotypes.
SUMMARY
Cellular senescence permanently arrests cell proliferation, often accompanied by a multi-faceted senescence-associated secretory phenotype (SASP). Loss of mitochondrial function can drive age-related declines in the function of many post-mitotic tissues, but little is known about how mitochondrial dysfunction affects mitotic tissues. We show here that several manipulations that compromise mitochondrial function in proliferating human cells induce a senescence growth arrest with a modified SASP that lacks the IL-1-dependent inflammatory arm. Cells that underwent mitochondrial dysfunction-associated senescence (MiDAS) had lower NAD+/NADH ratios, which caused both the growth arrest and prevented the IL-1-associated SASP through AMPK-mediated p53 activation. Progeroid mice that rapidly accrue mtDNA mutations accumulated senescent cells with a MiDAS SASP in vivo, which suppressed adipogenesis and stimulated keratinocyte differentiation in cell culture. Our data identify a distinct senescence response and provide a mechanism by which mitochondrial dysfunction can drive aging phenotypes.
INTRODUCTION
Age is the largest risk factor for myriad pathologies, ranging from neurodegeneration to cancer. These pathologies likely arise from a loss of tissue homeostasis driven by one or more basic aging process, together with stochastic, genetic, and environmental factors (Vijg and Campisi, 2008) . Mitochondria are potential drivers of aging phenotypes. Dysfunctional mitochondria accumulate with age, best documented in tissues comprised largely of post-mitotic cells (e.g., muscle cells and neurons) (Herbst et al., 2007; Lee et al., 2010; Safdar et al., 2010; Wallace, 2010) . Less is known about how dysfunctional mitochondria drive aging in mitotically active tissues, despite evidence from murine models that these tissues experience age-related degeneration when mitochondria are compromised (Kang et al., 2013; Kujoth et al., 2005; Trifunovic et al., 2004) .
One consequence of mitochondrial dysfunction is cellular senescence, a complex stress response by which proliferative cells permanently lose the ability to divide (Braig and Schmitt, 2006; Campisi and d'Adda di Fagagna, 2007) . The senescence response suppresses the development of cancer (Campisi, 2003; Campisi, 2013) , but there is mounting evidence that senescent cells can accumulate with age and cause or contribute to aging phenotypes and pathologies. The permanent growth arrest can deplete progenitor or stem cell pools, thereby compromising tissue repair and regeneration (Kuilman et al., 2010; Sousa-Victor et al., 2014; Velarde et al., 2015) . Further, senescent cells secrete molecules with potent paracrine effects (Coppé et al., 2006 (Coppé et al., , 2008 . This senescence-associated secretory phenotype (SASP) comprises pro-inflammatory cytokines, proteases, and growth and angiogenesis factors (Coppé et al., 2008) that can disrupt tissue microenvironments and compromise tissue structure and function.
Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al., 2010; Kang et al., 2013) . However, little is known about the mechanisms that mediate this effect. Some studies implicate mitochondrial reactive oxygen species (ROS) as causal (Jiang et al., 2013b; Moiseeva et al., 2009; Passos et al., 2010; Velarde et al., 2012) , but other outcomes of mitochondrial dysfunction are also likely. For example, sustained activation of 5 0 AMP-activated protein kinase (AMPK), a major bioenergetic sensor, is a hallmark of senescence (Moiseeva et al., 2009 ) and can induce a senescence arrest (Jiang et al., 2013b; Jones et al., 2005; Wang et al., 2003) . Unlike the growth arrest and markers such as senescence-associated b-galactosidase (SA-Bgal) (Dimri et al., 1995) , little is known about how mitochondria affect the SASP.
Because mitochondria oxidize NADH to NAD+ (Lehninger et al., 2013) , mitochondrial dysfunction can decrease the NAD+/NADH ratio. While mitochondria oxidize NADH generated by the tricarboxylic acid (TCA) cycle or fatty acid oxidation, they also oxidize the cytosolic NAD +/NADH pool through the a-glycerophosphate and malate-aspartate shuttles (Houtkooper et al., 2010) . Inhibition of the latter by depletion of malate dehydrogenase lowers the NAD+/NADH ratio and induces a senescence arrest (Lee et al., 2012) , suggesting that elevated cytoplasmic NADH can drive cells into senescence. Notably, NAD+ declines with age in several tissues (Braidy et al., 2011; Gomes et al., 2013; Stein and Imai, 2014; Yoshino et al., 2011) , linking NAD to both senescence and aging.
In a screen of sirtuins (SIRTs)-protein deacetylases, desuccinylases, demalonylases, deacylases, and ADP-ribose transferases (Hirschey, 2011; Jiang et al., 2013a) that are linked to aging (Haigis and Sinclair, 2010; Merksamer et al., 2013) -for ability to regulate senescence, we identified the mitochondrial SIRTs SIRT3, and to a lesser extent SIRT5, as suppressors of senescence and modulators of the SASP. Other mitochondrial perturbations induced a similar senescent phenotype, which we term mitochondrial dysfunction-associated senescence (MiDAS). We show that MiDAS results from a decreased NAD+/NADH ratio, activation of AMPK and subsequently the tumor suppressor p53, which then limits the IL-1 mediated arm of the SASP. Despite lacking IL-1-dependent SASP factors, the MiDAS SASP suppressed adipocyte differentiation and promoted keratinocyte differentiation. These phenotypes occurred in cultured human cells and a murine model of premature aging through mitochondrial dysfunction, thus linking mitochondrial dysfunction and aging through a subset of senescence phenotypes across species and in vivo.
RESULTS

Mitochondrial SIRTs Suppress Senescent Phenotypes
To determine whether SIRTs regulate senescence responses, we used lentiviruses to express shRNAs that target each of the seven human SIRTs in IMR-90 or BJ1 human fibroblasts. Immunoblots confirmed depletion of all seven SIRTs to different extents ( Figures 1A and S1A) . Surprisingly, depletion of SIRT3 or SIRT5, but not other SIRTs, induced senescence as judged by increased SA-Bgal activity and decreased BrdU labeling 10 days later. SIRT3 showed a stronger response, likely because it was more efficiently depleted ( Figures 1A, 1B , S1B, and S1C). Cells induced to senesce by ionizing radiation (IR) (10 Gy), a common senescence inducer (Coppé et al., 2008; Rodier et al., 2009) , showed no change in SIRT3 mRNA or protein (Figure S1D ), indicating that reduced SIRT3 expression does not comprise the senescence response. Nonetheless, SIRT3 depletion induced three senescence markers: reduced lamin B1 (LMNB1) levels (Freund et al., 2012) , decreased nuclear localization of high mobility group protein B1 (HMGB1) (Davalos et al., 2013) , and increased levels of the cell-cycle inhibitor p21 WAF1 (Campisi and d'Adda di Fagagna, 2007) (Figures 1C and 1D ).
To determine whether mitochondrial SIRT depletion induces a SASP (Coppé et al., 2008) , we measured secretion of IL-6, a major SASP factor, 10 days after SIRT3 or SIRT5 depletion. Despite the induction of other senescence markers, neither SIRT depletion increased IL-6 secretion ( Figure 1E ). Further, IR, a robust IL-6 inducer in unmodified cells, also failed to induce IL-6 secretion in SIRT3-depleted (and to a lesser extent SIRT5-depleted) cells (Figures 1E and S1E) . In contrast, IR induced IL-6 secretion in cells depleted of SIRT2, SIRT4, SIRT6, or SIRT7 ( Figure S1E ); it induced cell death after SIRT1-depletion (not shown), as reported (Cheng et al., 2003; Yuan et al., 2012) . Additional shRNAs confirmed the failure to induce IL-6 secretion in the absence of SIRT3 ( Figures S1F and S1G) . Thus, senescence resulting from depleted SIRT3, and to a lesser extent SIRT5, failed to include the SASP factor IL-6. Further, mitochondrial SIRT depletion suppressed IL-6 secretion by cells induced to senesce by IR.
SASPs result primarily from increased mRNA abundance (Coppé et al., 2008) . We analyzed control and SIRT3-depleted cells, with or without IR, for IL-6 and other SASP mRNAs by qPCR. SIRT3-depleted cells failed to express significant levels of the SASP mRNAs encoding IL1B, CXCL1, CXCL2, IL-6, IL-8 and VEGF, but expressed high levels of mRNAs encoding the SASP factors AREG and IL-10, regardless of IR exposure (Figure 1F) . Antibody arrays, which interrogate a different but overlapping set of SASP proteins, confirmed that SIRT3-depleted cells failed to secrete IL-1b, CXCL1, CXCL2, IL-6, IL-8, and VEGF ( Figure 1G ). Thus, SIRT3 depletion induced senescence but with a SASP that differed from that induced by IR, suggesting a mitochondrial function is required for expression of a subset of SASP factors. Notably, many SASP factors that were not expressed by SIRT3-depleted cells are pro-inflammatory, although the cells uniquely secreted CCL27 ( Figure 1G ), a pro-inflammatory cytokine that comprises the SASP of mouse, but not human, fibroblasts induced to senesce by IR (Coppé et al., 2010) .
To determine whether SIRT3 depletion suppressed SASP factors in response to senescence inducers other than IR, we treated SIRT3-depleted cells with the HDAC inhibitor sodium butyrate (NaBu) or the clastogen bleomycin (Bleo), or expressed oncogenic RAS or constitutively active MKK6 (MKK6EE), all of which induce a growth arrest and IR-like SASP (Coppé et al., 2008; Freund et al., 2011; Ogryzko et al., 1996; Orjalo et al., 2009) . SIRT3 depletion strongly suppressed IL-6 secretion by cells induced to senesce by IR, NaBu, or Bleo ( Figure 1H ) and moderately suppressed IL-6 secretion in response to MKK6EE or RAS ( Figure 1I ), suggesting that multiple SASP inducers require a pathway in which SIRT3 acts. Surprisingly, while SIRT3 shRNA induced senescence in wild-type (WT) mouse embryonic fibroblasts (MEFs), MEFs from SIRT3 knockout mice did not senesce (Figures S1H and S1I), indicating that an absence of SIRT3 throughout embryogenesis and acute loss of SIRT3 after development can have different effects, as reported (Fernandez-Marcos et al., 2012) .
Mitochondrial Dysfunction and Senescent Phenotypes
Because SIRT3 and SIRT5 are mitochondrial proteins, the above senescence responses might be a general effect of mitochondrial dysfunction. We therefore depleted mtDNA in IMR-90 cells by passage in ethidium bromide (rho0 cells) (Figures 2A and S2A ) (Nass, 1972) , treated cells with the electron transport chain inhibitors rotenone (Rot) or antimycin A (Anti A) ( Figure 2A ) or depleted cells of the mitochondrial chaperone HSPA9, which was shown to induce senescence (Yaguchi et al., 2007) (Figure 2A ). All treatments induced senescence as determined by reduced EdU incorporation, increased SA-Bgal activity (Figures 2A and S2B) , and loss of nuclear HMGB1 (for rho0 and Rot; Figure 2C ), but without an increase in IL6 mRNA levels and IL-6 protein secretion, even after 10 Gy IR ( Figures 2B, S2C , and S2D). We conclude that mitochondrial dysfunction causes a senescent phenotype that overlaps yet differs from that caused by other senescence inducers.
To better understand MiDAS, we cultured WT and rho0 IMR-90 cells and human mesenchymal stem cells (MSCs) with uridine and pyruvate, which prevents the rho0 growth arrest (Morais et al., 1994) . Upon pyruvate withdrawal, rho0, but not WT, cells rapidly senesced, as measured by low EdU labeling and high SA-Bgal ( Figures 2D and 2E ). Pyruvate also prevented the Rot- expression of these factors declined to near WT levels (Figures 2F and S2F) , and the cells arrested growth ( Figure 2D ), suggesting that MiDAS depends on a mitochondrial function for which pyruvate compensates. ROS are thought to mediate senescence in response to mitochondrial dysfunction (Moiseeva et al., 2009) . Although shSIRT3 and rho0 cells cultured without pyruvate had elevated Mitosox fluorescence ( Figures S2G and S2H ), normalization to Mitotracker showed roughly equivalent ROS levels between control and SIRT3-depleted cells ( Figure S2G ). Further, the antioxidant EUK-134 reduced mitochondrial, but not cytoplasmic, ROS in SIRT3-and HSPA9-depleted cells ( Figures S2I and S2J ) but did not prevent the growth arrest of these or Rot-treated cells ( Figures S2K and S2L ). Mitochondrial ROS is linked to senescence through nuclear DNA damage (Passos et al., 2010) , but rho0 and SIRT3-depleted cells showed no increase in 53BP1 foci ( Figures S2M-S2O ), a DNA damage marker, and EUK-134 had no effect on these foci in any senescent cell ( Figure S2O ). Thus, MiDAS phenotypes appear to be independent of ROS and DNA damage.
Decreased NAD+/NADH Ratios Mediate MiDAS
Pyruvate is at the nexus of glycolysis and the TCA cycle. In response to mitochondrial dysfunction or hypoxia, lactate dehydrogenase converts pyruvate to lactate, concomitantly converting cytosolic NADH to NAD+. NAD+ is required for glycolysis, whereas NADH inhibits glycolysis (Lehninger et al., 2013) . We tested the idea that the NAD+/NADH ratio regulates MiDAS by measuring each metabolite in lysates from WT and rho0 cells cultured with or without pyruvate. The NAD+/NADH ratio declined in rho0, Rot-treated, and SIRT3-depleted cells cultured without, but not with, pyruvate ( Figures 3A, S3A , and S3B). Surprisingly, while the NAD+/NADH ratio declined with MiDAS, total NAD+ actually increased ( Figure S3C ) along with a rise in nicotinamide phosphoribosyltransferase (NAMPT) mRNA ( Figure S3D ), suggesting that pyruvate acts by altering NAD redox status.
To determine whether the cytosolic or mitochondrial NAD+/ NADH ratio drives MiDAS, we measured NADH in each compartment using two-photon emission spectrometry. In WT cells, lactate increased NADH levels in the cytosol but not mitochondria ( Figures S3E and S3F) . Conversely, pyruvate lowered NADH in the cytosol, while increasing NADH in mitochondria, and rotenone elevated NADH in both the mitochondria and cytosol. In rho0 cells, lactate elicited only a small cytosolic response, suggesting that NADH was already reduced in this compartment. Likewise, pyruvate lowered cytosolic NADH to a much larger degree than in WT cells; it also lowered mitochondrial NADH in rho0 cells, but to a lesser extent than in the cytosol. Thus, MiDAS reduced the NAD+/NADH ratio mostly in the cytosol.
If decreased cytosolic NAD+/NADH drives MiDAS, NADH oxidation should prevent MIDAS. We treated pyruvate-free rho0 cells with potassium ferricyanide (K 3 [Fe(CN) 6 ]), a cellimpermeable electron acceptor and NADH oxidase substrate that transfers reducing equivalents across the plasma membrane and allows rho0 cells to proliferate (Martinus et al., 1993) . K 3 [Fe(CN) 6 ] prevented senescence, as determined by SA-Bgal and arrested growth, in both rho0 and Rot-treated cells ( Figures 3B and 3C) .
NADH reducing equivalents are transferred across the mitochondrial membrane by the malate-aspartate shuttle (Lehninger et al., 2013) , and depletion of the shuttle component malate dehydrogenase-1 induces a senescence arrest (Lee et al., 2012) . Aminooxyacetate (AOA) inhibits the shuttle, lowering the cytosolic, but not mitochondrial, NAD+/NADH ratio (Ló pez-Alarcó n and Eboli, 1986). AOA-treated WT cells underwent senescence (high SA-Bgal, low EdU labeling, loss of nuclear HMGB1; Figures  3D, 3E , S3G, and S3H) but failed to secrete IL-6 following IR, despite slightly higher secretion by unirradiated AOA-treated cells ( Figure 3F ). Importantly, pyruvate rescued the arrest of AOA-treated cells ( Figures 3G and S3H) . We also artificially increased NAD+/NADH ratios by treating rho0 cells with the NAD+ precursor nicotinamide mononucleotide (NMN) without pyruvate. NMN delayed senescence by $2 days relative to untreated cells ( Figure S3I ), but both groups senesced within 7 days ( Figures S3I and S3J) . Further, when we depleted NAD+ by preventing NAD salvage using the NAMPT inhibitor FK866, cell proliferation ceased after $7 days (Figure S3K ) and cells became senescent after $21 days (low EdU labeling, high SA-Bgal) ( Figures 3H and S3L ). In addition, FK866 suppressed IR-induced IL-6 secretion ( Figure 3I ) and lowered total NAD levels ( Figure 3J ). We conclude that low NAD+/ NADH ratios mediate MiDAS phenotypes, which are prevented by NADH oxidation.
Finally, SIRT3 activity requires NAD+ as a coenzyme, in which case loss of mitochondrial NAD+ and reduced SIRT3 function might account for MiDAS phenotypes. However, pyruvate withdrawal from rho0 cells decreased rather than increased acetylation at lysine 68 of SOD2-a known SIRT3 target ( Figures S3M  and S3N ). Thus, MiDAS cells do not senesce owing to loss of SIRT3 function per se.
Low NAD+/NADH Ratios Drive MiDAS through AMPK
Because NAD+ is required for glycolysis and NADH inhibits glycolysis, the NAD+/NADH ratio regulates energy production. We therefore measured ADP:ATP ratios in WT, rho0, SIRT3-depleted, and Rot-or Anti A-treated cells. All these manipulations elevated the ADP:ATP ratio ( Figure 4A ), which was lowered by pyruvate ( Figure S4A ). Similarly, rho0 cells showed elevated AMP:ATP ratios ( Figure S4B ), and inhibition of glycolysis by 2-deoxyglucose (2-DG) induced senescence in rho0, but not WT, cells, regardless of the presence of pyruvate ( Figures 4B and  S4C ). 2-DG alone did not alter NAD+/NADH ratios ( Figure S4D ).
Increased ADP:ATP or AMP:ATP ratios activate AMPK (Hardie et al., 2012) , which can induce senescence by phosphorylating p53 (Jones et al., 2005) or stabilizing p16
INK4a mRNA (Chang et al., 2010) , making AMPK activation a plausible candidate for mediating MiDAS. We therefore analyzed by immunoblot cells expressing control or SIRT3 shRNAs, and WT and rho0 cells, all cultured with or without pyruvate. Pyruvate reduced AMPKa phosphorylation (activation) in all cells. However, only MiDAS cells showed marked activation of both AMPKa (thr-172 phosphorylation) and p53 (ser-15 phosphorylation), both of which were blunted by pyruvate ( Figure 4C ). MiDAS also increased p21 WAF1 and p16 INK4a and decreased LMNB1 and intracellular HMGB1 protein levels, which were prevented by pyruvate. Similar results were obtained in cells treated with Rot or FK866 ( Figures S4E and S4F ). Treatment with a combination of 2-DG, pyruvate and Anti-A also activated AMPK ( Figure S4G ).
We also depleted AMPK using siRNAs, which prevented p53 phosphorylation and p21 WAF1 expression in SIRT3-depleted cells ( Figure 4D ). Because siRNA depletion was too transient to assess other senescence markers, we used a lentivirus to stably express a FLAG-tagged dominant-negative (kinase-dead) AMPK mutant (AMPK-DN). AMPK-DN conferred resistance to senescence induced by SIRT3 depletion, Rot, or Anti-A, as assessed by high SA-Bgal, low EdU labeling ( Figures 4E and 4F ), p53 phosphorylation, high p16 INK4a and p21 WAF1 expression, and low intracellular HMGB1 ( Figures S4H and S4I) . Together, the results indicate that AMPK activation mediates MiDAS.
AMPK Mediates MiDAS through p53
Because p53 initiates the senescence arrest and is an AMPK target (Jiang et al., 2013b; Jones et al., 2005) , we assessed the p53 dependence of MiDAS. We expressed control or p53 shRNAs in cells depleted of SIRT3, HSPA9, or mtDNA and analyzed them 7 days later for SA-Bgal, EdU labeling, and p21 WAF1 levels ( Figure 5A ). p53 loss suppressed the induction of these senescence markers ( Figures 5B, 5C , S5A, and S5B).
Because p53 also limits SASP gene expression (Coppé et al., 2008; Rodier et al., 2009 ), we depleted p53 in WT and rho0 cells and measured IL1A and IL1B mRNA levels. IL-1a and IL-1b initiate a positive feedback loop that drives expression of SASP factors such as IL-6 and IL-8 (Orjalo et al., 2009 ). p53 loss restored IL1A and IL1B expression to rho0 cells lacking pyruvate to levels near those of rho0 cells cultured with pyruvate ( Figure 5D ). IR robustly activates p53, which subsides to a low chronic level in 7-10 days as the SASP develops (Coppé et al., 2008; Rodier et al., 2009) . Although IR induced a SASP in WT cells with or without pyruvate, rho0 cells plus pyruvate expressed an enhanced SASP that was suppressed by IR ( Figures 5E and  S5C ). Since both IR and mitochondrial dysfunction activate p53 ( Figure 4C ), we conclude that p53 limits the expression of selected SASP factors during MiDAS.
p53 can suppress NF-kB (Dey et al., 2007; Murphy et al., 2011) , which promotes transcription of many SASP genes (Freund et al., 2011 ). An NF-kB reporter showed that NF-kB activity was high in rho0 cells cultured with pyruvate but much lower in rho0 cells without pyruvate ( Figure 5F ). IR increased NF-kB activity in WT cells, as reported (Freund et al., 2011) , but failed to do so in rho0 cells without pyruvate and reduced NF-kB activity to below that of unirradiated rho0 cells cultured with pyruvate ( Figure 5F ). These responses correlated with IL1A and IL1B mRNA levels ( Figure 5E ), suggesting that lack of the IL-1 signaling loop in MiDAS is due to suppression of NFkB activity. Indeed, although the RELA NF-kB subunit increased binding to the IL1A promoter in rho0 cells cultured with or without pyruvate, binding of the NF-kB coactivator CBP increased in rho0 cells with pyruvate, but not without pyruvate ( Figure 5G ). Since p53 inhibits RELA by competing for CBP binding (Webster and Perkins, 1999) , p53 likely limits the IL1 arm of the SASP by reducing NF-kB activity.
To further test this idea, we used shRNAs to deplete RELA from WT and rho0 cells cultured with pyruvate ( Figure S5D ). RELA depletion reduced several IL-1-responsive mRNAs (Figure 5H) . Of interest, it also reduced mitochondrially encoded COX2 protein levels ( Figure S5D ), implicating RELA in retrograde signaling. Notably, some secreted factors were unaffected by MiDAS and were insensitive to pyruvate. Examples include the pro-inflammatory cytokines CCL27 ( Figure 1G ) and TNF-a (Figure 5I ) and the anti-inflammatory cytokine IL-10 ( Figure 5I ).
MiDAS in POLG Mice
To determine whether MiDAS occurs in vivo, we analyzed POLG D257A mice, which have a mutation in the proofreading domain of the mtDNA polymerase (PolG) and rapidly accumulate mtDNA mutations and aging phenotypes (Kujoth et al., 2005; Trifunovic et al., 2004 S6D ) and loss of HMGB1 in suprabasal epidermal nuclei ( Figures S6E and S6F) . Thus, senescent cells accumulated in vivo in response to mitochondrial dysfunction caused by the POLG D257A mutation. To confirm MiDAS phenotypes in vivo, we measured NAD+/ NADH ratios in IAT from 8-month-old WT and POLG D257A mice. The ratios varied among individual mice but were significantly less in POLG D257A compared to WT IAT ( Figure 6F ).
NAD+/NADH ratios were also lower in the colon and small intestine of POLG D257A mice (Figures S6G-S6I) . Further, IL1A, IL1B, and IL6 mRNAs were unchanged, while IL10 and TNF mRNAs were higher ( Figure 6G ), in POLG D257A compared to WT IAT, indicating that the MiDAS SASP occurs in vivo in POLG D257A mice.
Because MiDAS occurred in POLG D257A fat and skin, which display aging phenotypes in these mice (Trifunovic et al., 2004) , we asked whether the MiDAS SASP can influence adipocyte and/or keratinocyte phenotypes. Conditioned medium (CM) from rho0 fibroblasts blocked adipogenesis in 3T3-L1 preadipocytes, as measured by oil red O staining ( Figure 6H ) and levels of mRNAs encoding the adipogenic markers C/EBPb, PPARg, and FABP4 ( Figure 6I ) in a pyruvate-independent manner. Further, conditioned media from rho0 cells promoted keratinocyte differentiation, as determined by staining for the differentiation markers transglutaminase (TGM1) and loricrin (LOR) (Figure S6J ), loss of EdU labeling ( Figure S6K ) and increased levels of mRNAs encoding CD36 and DGAT2 ( Figure S6L ). These data support the findings that epidermal-specific SOD2-deficient mice rapidly accumulate senescent keratinocytes, which show enhanced differentiation (Velarde et al., 2015) and that POLG D257A mice have a thicker stratum corneum and lipodystrophy compared to age-matched WT mice (Trifunovic et al., 2004) .
DISCUSSION
Mitochondrial dysfunction has been linked to aging (Khrapko and Vijg, 2009 ), but it is not clear how it drives aging, particularly in mitotic tissues. We show that (1) mitochondrial dysfunction induces a senescence response (MiDAS), including arrested growth and a SASP that is distinct from that caused by genotoxic stress; (2) preadipocytes and keratinocytes; and (6) MiDAS occurs in a progeroid mouse that rapidly accumulates dysfunctional mitochondria. Our findings provide a basis for how dysfunctional mitochondria can drive distinct aging phenotypes. Mitochondrial ROS can damage nuclear DNA, thus activating a DNA damage response that induces senescence (Moiseeva et al., 2009; Passos et al., 2010) . In MiDAS, pyruvate, but not an antioxidant, prevented MiDAS, which showed no evidence of DNA damage. Rather, decreased NAD+/NADH ratios caused MiDAS. In addition, because pyruvate prevented the MiDAS growth arrest but restored NF-kB activity, pyruvate uncoupled the growth arrest from the SASP in cells with compromised mitochondria. It is possible, however, that ROS activates NF-kB and hence the inflammatory arm of the SASP in pyruvatetreated cells.
Our finding that loss of SIRT3 loss drives senescence appears to contradict a report in which cells from SIRT3 knockout mice were highly susceptible to oncogenic transformation; however, this susceptibility depended on the elevated ROS characteristic of sirt3 À/À cells (Kim et al., 2010) . We reported that elevated oxygen dampens the SASP in humans and mouse cells (Coppé et al., 2010; Parrinello et al., 2003) . Other reports show that inducible SIRT3 knockout mice do not necessarily phenocopy germline knockout animals (Fernandez-Marcos et al., 2012) , consistent with our finding that acute SIRT3 depletion induces senescence. We show that low NAD+/NADH ratios drive MiDAS through the energy sensor AMPK. AMPK can induce senescence (Jiang et al., 2013b; Jones et al., 2005) by phosphorylating p53 on ser-15 (Jones et al., 2005) , a modification that drives cell-cycle arrest and senescence in response to genotoxic stress, and by preventing cytoplasmic translocation of the mRNA-stabilization factor HuR, thereby reducing pro-proliferation mRNAs (Wang et al., 2003) and stabilizing p16
INK4a mRNA (Chang et al., 2010) .
Because p53 depletion was sufficient to prevent MiDAS, AMPK most likely mediates MiDAS through p53 activation, and subsequent NF-kB inhibition. Our data from POLG D257A mice indicate that MiDAS can occur in vivo, although mtDNA mutations accumulate with age at rates well below that seen in POLG D257A mice (Khrapko and Vijg, 2009 ). However, aging also entails loss of mitochondrial function (Schriner et al., 2005) , and we show many forms of mitochondrial dysfunction result in MiDAS. Further, our data from POLG D257A mice indicate that the IL1-regulated arm of the SASP is not active in MiDAS in vivo, suggesting that mitochondrial dysfunction drives aging phenotypes through other SASP components. MiDAS cells secreted the anti-inflammatory cytokine IL-10, but also high levels of the pro-inflammatory cytokines CCL27 and TNF-a. In addition, they secreted HMGB1, a pro-inflammatory alarmin that is a feature of senescent cells (Davalos et al., 2013 ). While we have not identified all components of the MiDAS SASP, our finding that the secretions from MiDAS cells inhibit adipogenesis and promote keratinocyte differentiation suggest the MiDAS SASP can have potent paracrine effects in vivo.
In conclusion, we describe a distinct senescent phenotype associated with compromised mitochondria (MiDAS) in human cells and mice. MiDAS results from an NADH-AMPK-p53-dependent pathway and elicits a SASP that lacks IL-1-dependent factors but includes others. Our results underscore the plasticity of senescent phenotypes and explain how the agerelated increase in dysfunctional mitochondrial might drive aging phenotypes and pathologies.
EXPERIMENTAL PROCEDURES
Cell Culture IMR-90 human fibroblasts were mycoplasma-free, cultured in 3% O 2 as described (Coppé et al., 2008; Rodier et al., 2009) , and used between 25 and 40 population doublings. To generate rho0, cells were cultured in 100 ng/ml ethidium bromide, 100 mM sodium pyruvate, and 50 mg/ml uridine for 2 months. Cells were mock irradiated or irradiated with 10 Gy X-rays, as described in Rodier et al. (2009) , or treated with 100 nM rotenone, 10 nM antimycin A, 400 uM animooxyacetate (AOA), 1 mM NaBu, 2 mM 2-deoxyglucose, or 20-40 nM FK866 for 7-10 days unless noted otherwise. Cells were treated with 50 mg/ml Bleo in 20% O 2 as described (Orjalo et al., 2009 ).
Animals
Protocols were approved by the Institutional Animal Care and Use Committee. POLG D257A homozygotes were derived from heterozygous breeders, fed ad libitum from weaning, and aged to 8 months prior to tissue harvest.
SA-Bgal SA-Bgal activity was detected as described (Dimri et al., 1995) using a commercial kit (Biovision).
Immunofluorescence Cells were cultured with BrdU (20 mM) or EdU (10 mM) for 24 or 72 hr, fixed in 4% buffered formalin for 10 min, washed, and permeabilized in 0.5% Triton X-100 for 30 min. For BrdU, cells were incubated with Exonuclease III and DNase I for 1 hr. For EdU, cells were treated as instructed by the manufacturer (Life Technologies Cat #C10337). For HMGB1, cells were processed as described (Davalos et al., 2013) .
Immunohistochemistry
Tissues were fixed and stained for SA-Bgal as described above, followed by a second fixation in 10% buffered formalin, embedding in paraffin, and sectioning (5-7 mM). Sections were incubated overnight with HMGB1 antibody, and histochemistry was performed using the Vectastain Elite ABC KIT (Vector Labs) as instructed by the manufacturer.
NAD+/NADH Ratios Cells were made quiescent by incubating in 0.2% serum for 3 days. NAD and NADH were measured using a commercial kit (Biovision) and 5 3 10 5 cells homogenized in 500 ml lysis buffer. For tissue, 20 mg were homogenized in 400 ml lysis buffer and clarified at 14,000 3 g for 5 min at 4 C. Supernatants were fractionated using 10 kDa cutoff filters (Millipore) and spun at 10,000 3 g for 45 min. To measure NADH, NAD+ was decomposed by incubation at 65 C for 30 min. Standard curves (5-200 pg/ml) were generated for quantification.
ADP/ATP Ratios Cells (5 3 10 4 ) in 12-well plates were treated as described in the text. One well/ treatment was analyzed for protein content by BCA assay. ADP/ATP ratios were measured using a kit (Biovision) as instructed by the manufacturer, and normalized to protein content.
Immunoblots
Cells were lysed in 5% SDS in 10 mM Tris, pH 7.4, and protein content determined by BCA assay. 40 mg protein was separated by electrophoresis and transferred to PVDF membranes. Membranes were blocked in TBST + 5% BSA, incubated overnight with primary antibody, washed in TBST, incubated with HRP-conjugated secondary antibody for 30 min, and visualized by chemiluminescence. Antibodies are listed in Supplemental Experimental Procedures.
PCR RNA was isolated from cells using a kit (QIAGEN), and from IAT using Qiazol, as instructed by the manufacturer. RNA (250 ng/ml) was used to synthesize cDNA, which was analyzed by qPCR using the universal probe library (Roche). mRNA levels were normalized to averages of actin and tubulin, unless noted otherwise. Primer sequences and probes are listed in Supplemental Experimental Procedures.
Secreted Factors 3 3 10 4 cells in 12-well plates were treated as indicated in the text, and cultured in 0.5-1 ml serum-free DMEM for 24 hr. CM were collected and clarified at 2,000 3 g for 10 min. Supernatants were transferred to a tube; cells were trypsinized and counted. CM (100 or 2.5 ml) were analyzed by colorimetric (R&D) or bead-based ELISAs (AlphaLISA, Perkin-Elmer) as instructed by the manufacturer and normalized to cell number. For antibody arrays, 2 3 10 5 cells in 6-well plates were cultured in 0.5-1 ml of serum-free DMEM for 24 hr. CM were collected and cells counted. CM were diluted, applied to the arrays (RayBio), and analyzed as described (Coppé et al., 2008; Freund et al., 2011) .
siRNAs Control, SIRT3, and AMPKa1/2 siRNAs (Santa Cruz) were packaged in Lipofectamine RNAiMAX (Life Technologies), and transfections were performed in Opti-MEM with replenishment each day for 3 days. Scrambled sequences served as controls.
Lentiviruses SIRT3 (TRCN 0000038892), HSPA9 (TRCN0000029450, TRCN0000029452), and scrambled shRNAs (in pLK0.1) were from Sigma (Cat # SHC002). p53 shRNA was described ). The AMPK-DN (D157A) (Zhou et al., 2009 ) cDNA was cloned into the DraI and XbaI sites of lentiviral vector 670-1 and packaged as described ).
Statistical Analysis
Data are presented either as representative examples or means of 3+ experiments. Data are represented as means + SEM. p values were obtained using
